Sunday, October 03, 2021 12:39:21 PM
Get in KITL .08-.10 news will be poppin
Recent DTCFF News
- Defence Therapeutics Announces Warrant Terms Amendment • Newsfile • 03/20/2026 10:00:00 PM
- Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000 • Newsfile • 03/09/2026 07:15:00 AM
- Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March • Newsfile • 03/02/2026 08:15:00 AM
- Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million • Newsfile • 02/27/2026 10:00:00 PM
- Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board • Newsfile • 02/10/2026 08:15:00 AM
- Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform • Newsfile • 02/04/2026 08:15:00 AM
- Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline • Newsfile • 01/28/2026 01:40:00 PM
- Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics • Newsfile • 01/21/2026 08:15:00 AM
- Defence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th • GlobeNewswire Inc. • 12/11/2025 01:35:00 PM
- Defence Therapeutics Announces AGM Results and Provides Corporate Updates • Newsfile • 12/10/2025 09:30:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for December 11th • GlobeNewswire Inc. • 12/09/2025 01:35:00 PM
- Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs • Newsfile • 12/04/2025 08:15:00 AM
- Defence Therapeutics Announces Convertible Debenture Conversion • Newsfile • 11/21/2025 11:03:00 PM
- Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology • Newsfile • 11/19/2025 08:15:00 AM
- Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs • Newsfile • 11/06/2025 08:15:00 AM
- Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models • Newsfile • 11/04/2025 08:15:00 AM
- Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025 • Newsfile • 10/23/2025 07:15:00 AM
- Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025 • Newsfile • 10/06/2025 07:15:00 AM
- Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations • Newsfile • 10/02/2025 07:15:00 AM
- Defence's Director, Strategy & Business Advisor Dr. Amie Phinney Discusses the Accum Platform on Money Talk Radio with Ellis Martin • Newsfile • 09/23/2025 01:15:00 PM
